Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the derazantinib gastric adenocarcinoma study is displayed instead of a 403 error page, with details on the study design, treatments, outcome measures, eligibility, and participating locations.
    Difference
    90%
    Check dated 2026-11-10T23:19:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:10:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s terminology transition and points visitors to updates and FAQs. The site revision changes from v3.7.1 to v3.7.2, while the study page remains inaccessible with a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-20T22:32:09.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:38:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, signaling that the study page is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-22T23:51:18.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.6.5 to v3.6.6, reflecting a new metadata version of the page.
    Difference
    0.0%
    Check dated 2026-09-01T19:55:28.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.